Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Weber

Showing results (141-150 of 252) with videos related to

Pageof 26
Sort By:
Antiviral Therapy|June 27, 2007
Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell countsAmanda Mocroft, Schlomo Staszewski, Rainer Weber, et al.
Antiviral Therapy|May 12, 2004
Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infectionGilbert R Kaufmann, Nina Khanna, Rainer Weber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2005
Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort StudyAndri Rauch, Martin Rickenbach, Rainer Weber, et al.
Journal of Virology|February 1, 2008
Potent human immunodeficiency virus-neutralizing and complement lysis activities of antibodies are not obligatorily linkedMichael Huber, Viktor von Wyl, Christoph G Ammann, et al.
AIDS (London, England)|March 22, 2008
Effects of cognitive behavioral stress management on HIV-1 RNA, CD4 cell counts and psychosocial parameters of HIV-infected personsSimona Berger, Tanja Schad, Viktor von Wyl, et al.
Antiviral Therapy|May 14, 2003
Shifts in cell-associated HIV-1 RNA but not in episomal HIV-1 DNA correlate with new cycles of HIV-1 infection in vivoMarek Fischer, Alexandra Trkola, Beda Joos, et al.
Journal of Virology|June 15, 2007
In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10Amapola Manrique, Peter Rusert, Beda Joos, et al.
BMC Gastroenterology|July 9, 2015
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected personsFlorian Bihl, Gladys Martinetti, Gilles Wandeler, et al.
Antiviral Therapy|April 9, 2008
Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patientsTracy R Glass, Sabina De Geest, Bernard Hirschel, et al.
Antiviral Therapy|December 3, 2003
Impact of genotypic resistance testing on selection of salvage regimen in clinical practiceStefan Haupts, Bruno Ledergerber, Jörg Böni, et al.
Pageof 26

Showing results (141-150 of 252) with videos related to

Sort By:
Pageof 26
Antiviral Therapy|June 27, 2007
Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell countsAmanda Mocroft, Schlomo Staszewski, Rainer Weber, et al.
Antiviral Therapy|May 12, 2004
Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infectionGilbert R Kaufmann, Nina Khanna, Rainer Weber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2005
Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort StudyAndri Rauch, Martin Rickenbach, Rainer Weber, et al.
Journal of Virology|February 1, 2008
Potent human immunodeficiency virus-neutralizing and complement lysis activities of antibodies are not obligatorily linkedMichael Huber, Viktor von Wyl, Christoph G Ammann, et al.
AIDS (London, England)|March 22, 2008
Effects of cognitive behavioral stress management on HIV-1 RNA, CD4 cell counts and psychosocial parameters of HIV-infected personsSimona Berger, Tanja Schad, Viktor von Wyl, et al.
Antiviral Therapy|May 14, 2003
Shifts in cell-associated HIV-1 RNA but not in episomal HIV-1 DNA correlate with new cycles of HIV-1 infection in vivoMarek Fischer, Alexandra Trkola, Beda Joos, et al.
Journal of Virology|June 15, 2007
In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10Amapola Manrique, Peter Rusert, Beda Joos, et al.
BMC Gastroenterology|July 9, 2015
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected personsFlorian Bihl, Gladys Martinetti, Gilles Wandeler, et al.
Antiviral Therapy|April 9, 2008
Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patientsTracy R Glass, Sabina De Geest, Bernard Hirschel, et al.
Antiviral Therapy|December 3, 2003
Impact of genotypic resistance testing on selection of salvage regimen in clinical practiceStefan Haupts, Bruno Ledergerber, Jörg Böni, et al.
Pageof 26